Searched for
PANACEA BIOTECH LTD
Rajat Sharma added Bandhan Bank and Panacea Biotech to his portfolios. Here’s why“Panacea Biotech restructured the company around Covid. They have paid off all their debt. It is a debt-free company. They got out of low p...- Panacea Biotec jumps 9% on manufacturing licence for Sputnik V vaccinePanacea Biotec said on Sunday the Indian drugs regulator granted the licence following the company's collaboration with the Russian Direct ...
- Panacea gets approval to make Sputnik V at its Himachal PlantNew Delhi-based Panacea Biotech has a collaboration with Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund which is bac...
- Adar Poonawalla transfers entire Panacea Biotec stake worth Rs 118 cr to Serum InstitutePoonawalla sold 3.15 million shares of Panacea Biotech at Rs 373.85 per share to Serum Institute in a block deal on the BSE earlier today.
- Panacea in talks with Bharat Biotech to make CovaxinExperts have called upon both companies to ramp up production and have asked the government to approve the use of more vaccines in the coun...
- Panacea Biotec enters collaboration with Bionpharma for generics worth $800 millionShare prices spiked upon the development, going as high as 9.75% (Rs 148 a piece) on the Bombay Stock Exchange before 11:00 am on Friday.
- Government nod to 15 FDI plans; CCEA to consider HDFC proposalThe proposals were cleared by Foreign Investment Promotion Board (FIPB) headed by the Economic Affairs Secretary in its meeting held earlie...
- Panacea Biotech Q1 net loss at Rs 60.92 crorePanacea Biotech Ltd today reported net loss of Rs 60.92 crore for the first quarter ended June 30, 2013.
- Panacea Biotec, Gurgaon builder to develop townshipPanacea Biotec and builder Bestech Group to jointly develop a township project over a 100-acre plot owned by Panacea in Gurgaon.
- Panacea Biotech enters into pact with Kremers Urban; stock upShares of Panacea Biotech gained momentum after the company entered into strategic alliance with Kremers Urban for 11 high barrier to entry...
- Drugmakers revive production of H1N1 vaccineZydus Cadila, Panacea Biotech and Serum Institute have resumed production of the swine flu vaccine as the once-pandemic disease threatens t...
- Laboratorios to market Panacea drug in EuropePanacea Biotec has signed a non-exclusive marketing agreement with Uruguay's Laboratorios Clausen SA, allowing the Latin American firm to m...
- WHO delists Shantha bestsellerShantha Biotech’s bread-winner vaccine has fallen out of favour with the World Health Organisation.
- Panacea Q4 net at Rs 57 cr; FY'10 profit at Rs 80 crPanacea Biotec today posted a net profit of Rs 57.52 crore for the fourth quarter ended March 31, 2010.
- Panacea's Baddi unit gets US FDA approvalDrug maker Panacea Biotec on Friday said its pharmaceutical facility at Baddi in Himachal Pradesh has received approval from US health regu...
- Coming soon: Swine flu vaccine made in IndiaIndia may soon get its own vaccine for swine flu, or the H1N1 virus, that has killed hundreds across the globe this year.
- Vaccine makers eye Unicef market for new launchesIndian vaccine makers have begun targeting the Unicef market to launch their novel vaccine molecules.
- Serum Institute hikes stake in Panacea Biotec to 7%India’s largest vaccine maker, Serum Institute of India, has picked up close to 7% stake in rival firm Panacea Biotec.
- Panacea, Intas plan biosimilar launchJoining Indian pharma majors who are targeting the $65-billion global biotech drug market.
- Panacea Biotech net up 104%Panacea Biotech announced a 103.5% jump in net profit for the period ended September ‘06 to Rs 46.5 crore, compared with Rs 22.87 crore dur...
Load More
